#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#
preLekára.sk / Journals / Perspectives in Surgery / 2024 - 5

Prophylactic osteosynthesis of long bones in patients with multiple myeloma

Česká verzia

Authors: V. Nekuda 1;  D. Ira 1;  M. Štork 2;  V. Válek 3;  Z. Knechtová 2;  M. Cvanová 4;  L. Pour 2;  M. Krtička 1
Authors place of work: Klinika úrazové chirurgie Fakultní nemocnice Brno a Lékařské fakulty Masarykovy univerzity Brno, Česká republika 1;  Interní hematologická a onkologická klinika Fakultní nemocnice Brno a Lékařské fakulty Masarykovy univerzity, Brno, Česká republika 2;  Klinika radiologie a nukleární medicíny Fakultní nemocnice Brno a Lékařské fakulty Masarykovy univerzity Brno, Česká republika 3;  Institut biostatistiky a analýz Lékařské fakulty Masarykovy univerzity Brno, Česká republika 4
Published in the journal: Rozhl. Chir., 2024, roč. 103, č. 5, s. 187-192.
Category: Original articles
doi: https://doi.org/10.33699/PIS.2024.103.5.187–192

Summary

Introduction: Multiple myeloma (MM) is a neoplastic disease caused by clonal proliferation of plasma cells in the bone marrow. The median age of newly diagnosed patients is 69 years. Bone involvement occurs in most patients during the course of the disease. The management of bone involvement in MM includes surgical intervention. Bones affected by osteolytic lesions are weakened and require stabilization through implants or endoprostheses. The intramedullary osteosynthesis method appears to be an ideal choice for stabilizing osteolytic lesions in long bones. The aim of our study was to analyze whether prophylactic fixation of these lesions improves the quality of life of the patients and has any impact on bone changes.

Methods: Patients undergoing prophylactic intramedullary osteosynthesis were operated on at the University Hospital Brno between 2013 and 2023. Patients included in this study had osteolytic lesions in long bones, Mirels’ score equal to or greater than 8, and a minimum follow-up of 12 months. We evaluated the intensity of pain using a visual analog scale (VAS) assessed before the operation, after the operation, and one-year post-operation. The Musculoskeletal Tumour Society score (MSTS) score was assessed just before the planned stabilization procedure and one year later.

Results: At the time of the assessment, a statistically significant difference was found between the VAS score before the operation and 14 days post-operation (p<0.001), as well as between the VAS score before the operation and one-year post-operation (p<0.001). The comparison of MSTS scores before the operation and one-year post-operation also showed statistical significance (p=0.006).

Conclusion: Prophylactic intramedullary stabilization of osteolytic lesions in MM patients is an effective method that reduces pain and improves the quality of life for these patients.

Keywords:

bone metastases – multiple myeloma – osteolytic lesion – prophylactic stabilization – intramedullary stabilization

Zdroje
  1. Adam Z, Hájek R, Mayer J, et al. Mnohočetný myelom a další monoklonální gamapatie. 1. vyd. MU Brno, Vydavatelství MU Kraví hora 1999:370.
  2. Maluskova D, Svobodová I, Kucerova M, et al. Epidemiology of multiple myeloma in the Czech Republic. Klin Onkol. 2017 Summer;30 (Supplementum2):35–42. doi:10.14735/amko20172S35.
  1. Terpos E, Berenson J, Raje N, et al. Management of bone disease in multiple myeloma. Expert Rev Hematol. 2014 Feb;7(1):113–125. doi:10.1586/17474086.2013.874943.
  2. Mundy GR, Bertolini DR. Bone destruction and hypercalcemia in plasma cell myeloma. Semin Oncol. 1986 Sep;13(3):291– 299.
  3. Terpos E, Szydlo R, Apperley JF, et al. Soluble receptor activator of nuclear factor κB ligand–osteoprotegerin ratio predicts survival in multiple myeloma: proposal for a novel prognostic index. Blood 2003 Aug 1;102(3):1064–1069. doi:10.1182/ blood-2003-02-0380.
  4. Galán-Olleros M, Marco J, Oteo D, et al. Orthopedic surgical treatment and perioperative complications in multiple myeloma bone disease: Analysis of a series (2009-2018). Ann Surg Oncol. 2021 Feb;28(2):1158–1166. doi:10.1245/ s10434-020-08819-6.
  5. Rajkumar SV. Multiple myeloma: 2022 update on diagnosis, risk stratification, and management. Am J Hematol. 2022 Aug;97(8):1086–1107. doi:10.1002/ ajh.26590.
  6. Momm F, Greil C, Schäfer H. Towards individualized radiation therapy in multiple myeloma. Haematologica 2020 Jul;105(7):1763–1764. doi:10.3324/haematol.2019.243451.
  7. Weber KL, Randall RL, Grossman S, et al. Management of lower-extremity bone metastasis. J Bone Joint Surg Am. 2006 Dec;88 Suppl 4:11–19. doi:10.2106/ JBJS.F.00635.
  8. Willeumier JJ, van der Linden YM, van de Sande MAJ, et al. Treatment of pathological fractures of the long bones. EFORT Open Rev. 2016 May;1(5):136–145. doi:10.1302/2058-5241.1.000008.
  9. Garcés JJ, Simicek M, Vicari M, et al. Transcriptional profiling of circulating tumor cells in multiple myeloma: a new model to understand disease dissemination. Leukemia 2020 Feb;34(2):589–603. doi:10.1038/s41375-019-0588-4.
  10. Utzschneider S, Schmidt H, Weber P, et al. Surgical therapy of skeletal complications in multiple myeloma. Int Orthop. 2011 Aug;35(8):1209–1213. doi:10.1007/ s00264-010-1127-0.
  11. Kobryn A, Nian P, Baidya J, et al. Intramedullary nailing with and without the use of bone cement for impending and pathologic fractures of the humerus in multiple myeloma and metastatic disease. Cancers 2023 Jul 13;15(14). doi:10.3390/cancers15143601.
  12. Ormsby NM, Leong WY, Wong W, et al. The current status of prophylactic femoral intramedullary nailing for metastatic cancer. Ecancermedicalscience 2016;10:698. doi:10.3332/ecancer.2016.698.
  13. Mirels H. Metastatic disease in long bones. A proposed scoring system for diagnosing impending pathologic fractures. Clin Orthop. 1989 Dec;(249):256–264.
  14. Hayes M. Experimental development of the graphic rating method. Psychol Bull. 1921;18:98–99.
  15. Enneking WF, Dunham W, Gebhardt MC, et al. A system for the functional evaluation of reconstructive procedures after surgical treatment of tumors of the musculoskeletal system. Clin Orthop. 1993 Jan;(286):241–246.
  16. Krtička M, Chovanec M, Smekal P, et al. Stable osteosynthesis of pathological fracture of long bones in patients with multiple myeloma; retrospective evaluation of the therapy. Uraz Chir. 2020 Mar 13;27:204–208.
  17. Dürr HR, Kühne JH, Hagena FW, et al. Surgical treatment for myeloma of the bone. Arch Orthop Trauma Surg. 1997 Oct 1;116(8):463–469. doi:10.1007/BF00387578.
  18. Blank AT, Lerman DM, Patel NM, et al. Is prophylactic intervention more cost-effective than the treatment of pathologic fractures in metastatic bone disease? Clin Orthop. 2016 Jul;474(7):1563–1570. doi:10.1007/s11999-016-4739-x.
  19. Ward WG, Holsenbeck S, Dorey FJ, et al. Metastatic disease of the femur: surgical treatment. Clin Orthop. 2003 Oct;(415 Suppl):S230–244. doi:10.1097/01.blo.000 0093849.72468.82.
  20. Damron TA, Morgan H, Prakash D, et al. Critical evaluation of Mirels’ rating system for impending pathologic fractures. Clin Orthop. 2003 Oct;(415 Suppl):S201–207. doi:10.1097/01.blo.000 0093842.72468.73.
  21. Gitelis S, Sheinkop MB, Hammerberg K, et al. The role of prophylactic surgery in the management of metastatic hip disease. Orthopedics 1982 Aug;5(8):1004–1011. doi:10.3928/0147-7447-19820801-08.
  22. Mosher ZA, Patel H, Ewing MA, et al. Early clinical and economic outcomes of prophylactic and acute pathologic fracture treatment. J Oncol Pract. 2019 Feb;15(2):e132–140. doi:10.1200/JOP.18. 00431.
  23. Cornelis FH, Tselikas L, Carteret T, et al. A novel implant for the prophylactic treatment of impending pathological fractures of the proximal femur: Results from a prospective, first-in-man study. Cardiovasc Intervent Radiol. 2017 Jul;40(7):1070–1076. doi:10.1007/s00270-017-1613-5.
  24. Nazarian A, Entezari V, Zurakowski D, et al. Treatment planning and fracture prediction in patients with skeletal metastasis with CT-based rigidity analysis. Clin Cancer Res. 2015 May 31;21(11):2514–2519. doi:10.1158/1078-0432.CCR-14-2668.
  25. Piccioli A, Maccauro G, Spinelli MS, et al. Bone metastases of unknown origin: epidemiology and principles of management. J Orthop Traumatol Off J Ital Soc Orthop Traumatol. 2015 Jun;16(2):81–86. doi:10.1007/s10195-015-0344-0.

MUDr. Vladimír Nekuda
Pechova 18
Brno 615 00
e-mail: nekuda.vladimir@fnbrno.cz
ORCID: 0000-0003-0644-8378

Štítky
Surgery Orthopaedics Trauma surgery
Článek Quo vadis trauma surgery in the Czech Republic
Článek Current treatment strategy for proximal humerus fractures
Článek Current clinical applications of 3D printing in the management of complex fractures
Článek Therapy of bone infection with an antibiotic cement-coated intramedullary nail – preliminary results
Článek Fractures of the posterior malleolus as a part of complex ankle fractures: Trends in diagnosis and treatment at our institution
Článek Conservative therapy for acromioclavicular joint dislocation – Rockwood III: a cohort analysis
Článek Intraosseous ganglion cyst of the scaphoid with an extraosseous component –an uncommon cause of volar wrist pain: case report and literature review
Článok vyšiel v časopise

Perspectives in Surgery

Číslo 5
2024 Číslo 5
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#